SF3B1-mutant MDS as a distinct disease subtype: a proposal from the International Working Group for the Prognosis of MDS by Malcovati, L, Stevenson, K, Papaemmanuil, E, Neuberg, D, Bejar, R, Boultwood, J, Bowen, DT, Campbell, PJ, Ebert, BL, Fenaux, P, Haferlach, T, Heuser, M, Jansen, JH, Komrokji, RS, Maciejewski, JP, Walter, MJ, Fontenay, M, Garcia-Manero, G, Graubert, TA, Karsan, A, Meggendorfer, M, Pellagatti, A, Sallman, DA, Savona, MR, Sekeres, M, Steensma, DP, Tauro, S, Thol, F, Vyas, P, Van de Loosdrecht, AA, Haase, DT, Tuechler, H, Greenberg, PL, Ogawa, S, Hellstrom-Lindberg, ES, Cazzola, M

“…American Society of Hematology…”

Non-del(5q) myelodysplastic syndromes-associated loci detected by SNP-array genome-wide association meta-analysis by McGraw, KL, Cheng, C-H, Chen, YA, Hou, H-A, Nilsson, B, Genovese, G, Cluzeau, T, Pellagatti, A, Przychodzen, BP, Mallo, M, Arenillas, L, Mohamedali, A, Adès, L, Sallman, DA, Padron, E, Sokol, L, Moreilhon, C, Raynaud, S, Tien, H-F, Boultwood, J, Ebert, BL, Sole, F, Fenaux, P, Mufti, GJ, Maciejewski, JP

“…American Society for Hematology…”

Gene expression and risk of leukemic transformation in myelodysplasia by Shiozawa, Y, Malcovati, L, Gallì, A, Pellagatti, A, Karimi, M, Sato-Otsubo, A, Sato, Y, Suzuki, H, Yoshizato, T, Yoshida, K, Shiraishi, Y, Chiba, K, Makishima, H, Boultwood, J, Hellström-Lindberg, E, Miyano, S, Cazzola, M, Ogawa, S

“…American Society of Hematology…”

Spliceosome mutations: 1 plus 1 does not always equal 2 by Pellagatti, A, Boultwood, J

“…American Society of Hematology…”

Aberrant overexpression of CD14 on granulocytes sensitizes the innate immune response in mDia1 heterozygous del(5q) MDS. by Keerthivasan, G, Mei, Y, Zhao, B, Zhang, L, Harris, C, Gao, J, Basiorka, A, Schipma, M, McElherne, J, Yang, J, Verma, A, Pellagatti, A, Boultwood, J, List, A, Williams, D, Ji, P

“…American Society of Hematology…”

Impact of spliceosome mutations on RNA splicing in myelodysplasia: dysregulated genes/pathways and clinical associations by Pellagatti, A, Armstrong, R, Steeples, V, Sharma, E, Repapi, E, Singh, S, Sanchi, A, Radujkovic, A, Horn, P, Dolatshad, H, Roy, S, Broxholme, J, Lockstone, H, Taylor, S, Giagounidis, A, Vyas, P, Schuh, A, Hamblin, A, Papaemmanuil, E, Killick, S, Malcovati, L, Hennrich, M, Gavin, A, Ho, A, Luft, T, Hellström-Lindberg, E, Cazzola, M, Smith, C, Smith, S, Boultwood, J

“…American Society of Hematology…”

miR-21 mediates hematopoietic suppression in MDS by activating TGF-β signaling. by Bhagat, T, Zhou, L, Sokol, L, Kessel, R, Caceres, G, Gundabolu, K, Tamari, R, Gordon, S, Mantzaris, I, Jodlowski, T, Yu, Y, Jing, X, Polineni, R, Bhatia, K, Pellagatti, A, Boultwood, J, Kambhampati, S, Steidl, U, Stein, C, Ju, W, Liu, G, Kenny, P, List, A, Bitzer, M, Verma, A

“…American Society of Hematology…”